Investment Rating - The report maintains a "Buy" rating for the company [5]. Core Viewpoints - The CT ball tube is a critical component of medical CT, accounting for approximately 20% of the total BOM cost of CT machines, and has high industry barriers due to its complex manufacturing requirements [1][18]. - The domestic market for CT ball tubes is expected to exceed 20 billion yuan by 2025, driven by high replacement demand and a shorter average replacement cycle compared to developed countries [2][47]. - The report highlights the urgent need for domestic substitution of CT ball tubes, as the current domestic substitution rate is less than 10% [4][50]. Summary by Sections 1. CT Ball Tube: The "Core" of Medical CT - The CT ball tube is essential for X-ray computed tomography systems, with its performance directly impacting image quality and diagnostic capabilities [15]. - The technology has evolved significantly, focusing on improving heat dissipation efficiency and overall performance [25]. 2. Market Size: High-Value Consumables with Broad Future Potential - The CT ball tube market is characterized by rigid replacement demand, with an average replacement cycle of 18 months in China due to high usage rates [2][45]. - The estimated market size for CT ball tubes in China is projected to reach over 20 billion yuan by 2025, with significant contributions from both new installations and replacement markets [47][48]. 3. Competitive Landscape: Overseas Manufacturers Dominate - Major global manufacturers like GPSC, Dunlee, and Varex dominate the CT ball tube market, with 85% of replacement tubes still relying on original manufacturer products [3][50]. - The report emphasizes the need for accelerated domestic production to reduce reliance on imports, as the current domestic substitution rate is low [4][50]. 4. Company Overview: Yirui Technology - Yirui Technology is positioned as a leading supplier of X-ray core components and comprehensive solutions, focusing on the development of CT ball tubes [5]. - The company plans to raise approximately 1.174 billion yuan to enhance its production capacity for X-ray vacuum components and solutions, aiming to significantly increase its output [9][10]. - Financial forecasts indicate strong revenue growth, with expected revenues of 2.405 billion yuan in 2025, reflecting a year-on-year increase of 31.3% [10].

Investment Rating - The report maintains an "Outperform" rating for the company [1][10]. Core Insights - In 2024, the company achieved revenue of RMB 1.83 billion, a decrease of 1.74%, with a net profit attributable to shareholders of RMB 465 million, down 23.43%. For Q1 2025, revenue was RMB 482 million, a decline of 1.92%, while net profit increased by 2.74% to RMB 143 million [10][11]. - The company has revised its EPS forecasts for 2025 and 2026 to RMB 4.07 and RMB 5.02, respectively, and introduced a new forecast for 2027 at RMB 6.22. The target price is set at RMB 143.10, corresponding to a 2025 PE of 35X [10][12]. Financial Summary - The company's revenue for 2024 is projected at RMB 2.22 billion, with a growth rate of 21.0% in 2025 and 22.0% in 2026. The net profit is expected to recover to RMB 583 million in 2025, with further growth anticipated in subsequent years [4][6]. - The company’s market share in the global digital X-ray detector industry reached 20.09% in 2023, indicating a solidified market position despite a decrease in sales revenue for detectors in 2024 [11][12]. Business Growth and Development - The new core components business saw a revenue increase of 45.49% in 2024, while integrated solutions and technical services revenue surged by 226.25% [12][13]. - The company is actively expanding its domestic and international markets, establishing sales and service platforms in various countries, including the USA, Germany, and India, which contributed to nearly RMB 100 million in revenue from new core components and solutions [13][12].

Investment Rating - The report maintains a "Buy" rating for the company [5]. Core Insights - The CT tube is a critical component of medical CT machines, accounting for approximately 20% of the total BOM cost. It has high technical barriers due to its complex requirements in development, design, and manufacturing [1][18]. - The domestic market for CT tubes is expected to exceed 20 billion yuan by 2025, driven by high replacement demand and a shorter average replacement cycle compared to developed countries [2][47]. - The report highlights the urgent need for domestic replacement of imported CT tubes, as the current domestic replacement rate is below 10%. Government policies are increasingly supportive of domestic innovation in this area [4][50]. Summary by Sections 1. CT Tubes: The "Core" of Medical CT - CT tubes are essential for X-ray computed tomography systems, with their performance directly impacting image quality and diagnostic capabilities [15]. - The technology has evolved significantly, focusing on improving heat dissipation, lifespan, and image quality [25][40]. 2. Market Size: High-Value Consumables with Broad Future Potential - The average replacement cycle for CT tubes in China is about 18 months, significantly shorter than the 2-4 years typical in developed countries [2][45]. - The market is segmented into OEM for new installations and aftermarket for replacements, with substantial growth expected in both areas [48]. 3. Competitive Landscape: Dominance of Overseas Manufacturers - Major global players like GE, Siemens, and Philips dominate the market, with a significant portion of the replacement tube market still relying on original manufacturer products [3][50]. - The report notes that 85% of replacement tubes globally are still original manufacturer tubes, indicating a strong market for domestic alternatives [3][50]. 4. Domestic Replacement: Urgent Need for Acceleration - The report emphasizes the low domestic replacement rate of CT tubes and the government's focus on promoting local production to reduce reliance on imports [4][50]. - Recent government initiatives, including anti-dumping investigations, are expected to create opportunities for domestic manufacturers [4]. 5. Company Overview: Yirui Technology as a Leading Supplier - Yirui Technology is positioned as a leading supplier of X-ray core components and comprehensive solutions, with a focus on expanding its product line in CT tubes [5]. - The company plans to raise approximately 1.174 billion yuan to enhance its production capacity for X-ray vacuum components and solutions [9]. 6. Financial Forecasts and Valuation - The company is projected to achieve revenues of 2.405 billion yuan in 2025, with a year-on-year growth of 31.3%. Net profits are expected to reach 702 million yuan, reflecting a growth of 51.0% [10][11]. - The report provides a detailed financial outlook, including EPS estimates and PE ratios, supporting the "Buy" rating [10].

Investment Rating - The report maintains an "Outperform" rating for the company [1][10]. Core Insights - In 2024, the company achieved revenue of RMB 1.83 billion (-1.74%), net profit attributable to shareholders of RMB 465 million (-23.43%), and recurring net profit attributable to shareholders of RMB 439 million (-25.84%). For Q1 2025, revenue was RMB 482 million (-1.92%), net profit attributable to shareholders was RMB 143 million (+2.74%), and recurring net profit attributable to shareholders was RMB 141 million (-9.19%) [10][11]. - The EPS forecasts for 2025-2026 have been revised to RMB 4.07 and RMB 5.02, with a new forecast for 2027 at RMB 6.22. The target price is set at RMB 143.10, corresponding to a 2025 PE of 35X [10][12]. Financial Summary - The company’s revenue for 2024 was RMB 1.83 billion, with a slight decline of 1.74% compared to the previous year. The net profit attributable to shareholders decreased by 23.43% to RMB 465 million [4][10]. - The company’s revenue for Q1 2025 was RMB 482 million, reflecting a decrease of 1.92% year-on-year, while net profit attributable to shareholders increased by 2.74% to RMB 143 million [10][11]. - The company’s financial forecasts indicate a revenue increase to RMB 2.22 billion in 2025 and RMB 2.70 billion in 2026, with net profit expected to rise to RMB 583 million and RMB 717 million respectively [4][10]. Market Position - The company continues to increase its market share in the detector market, achieving a global market share of 20.09% in 2023, despite a decline in sales revenue of digital X-ray detectors to RMB 1.49 billion in 2024 [11][12]. - The new core components business saw significant growth, with revenue increasing by 45.49% to RMB 126 million in 2024, while integrated solutions and technical services revenue surged by 226.25% to RMB 86.80 million [12][13]. Strategic Initiatives - The company is actively expanding its domestic and international markets, establishing overseas sales or customer service platforms in multiple countries including the USA, Germany, and India [13][12]. - The company has completed its business layout in high-voltage generators, radiation sources, and tubes, with several products beginning mass production in 2024 [12][13].

Core Viewpoint - Yirui Technology's 2024 annual report shows a slight decline in revenue and profit, but the company continues to focus on technological innovation, global expansion, and new business development to lay a solid foundation for future growth [2][3][5]. Financial Performance - In 2024, Yirui Technology achieved revenue of 1.831 billion yuan, a year-on-year decrease of 1.74% - The net profit attributable to shareholders was 465 million yuan, down 23.43% year-on-year [2][3]. Performance Review - The company faced short-term pressure due to weak global economic recovery, increased trade barriers, and sluggish downstream demand, leading to a slight decline in revenue and profit - Despite this, Yirui Technology demonstrated strong resilience by increasing R&D investment, optimizing the supply chain, and expanding into overseas markets - R&D investment reached 310 million yuan, accounting for 16.94% of revenue, with 115 new intellectual property rights added, including 30 invention patents [5]. Technological Innovation - Yirui Technology emphasizes technology as its core, achieving significant results in new product development and core technology breakthroughs in 2024 - In the medical field, the company launched high-resolution detectors and advanced products such as the 64-slice medical CT detector module - In the industrial sector, new products include flexible detectors and security CT detector modules, catering to diverse detection needs - The successful development of UEG series rare earth garnet scintillation ceramics fills a material gap in high-energy industrial CT imaging [6][7][8]. Global Expansion - To address domestic market pressures, Yirui Technology accelerated its global expansion - The company established sales or customer service platforms in various countries, including the USA, Germany, South Korea, and India, and participated in major global industry exhibitions to enhance brand influence - The production bases in Haining and Taicang (Phase II) have been put into operation, and the Cleveland factory in the USA is now operational, increasing the global factory layout to six locations, forming an international supply chain network [10][11]. Development Strategy - Yirui Technology has outlined six strategic directions, focusing on: - Technological self-control: Accelerating the localization of core components and promoting import substitution across the X-ray industry chain - Product high-end positioning: Focusing on cutting-edge technologies such as photon counting detectors and optimizing product structure - Global competition: Strengthening overseas R&D and sales networks to become the preferred brand for global customers - Cultivating new productive forces: Expanding into new businesses such as life science instruments to create a second growth curve [12][13][14][15]. Future Outlook - In 2025, Yirui Technology plans to continue increasing R&D investment, improving global layout, and enhancing operational efficiency through intelligent production and supply chain optimization - The company emphasizes a "big customer strategy" to deepen customer cooperation with differentiated products and services, further solidifying its global competitiveness in the X-ray core component field [16]. Conclusion - Despite short-term performance pressures in 2024, Yirui Technology showcases strong long-term growth potential through technological innovation and global strategies, steadily progressing towards its goal of becoming a leading global supplier of X-ray products and solutions [17].

Core Insights - The company is a leading domestic manufacturer of core components for X-ray imaging equipment, with a continuously increasing market share and rapid growth in new core components and comprehensive solution businesses, maintaining a buy rating [1] Financial Performance - In 2024, the company achieved revenue of 1.831 billion yuan (-1.74%) and a net profit attributable to shareholders of 465 million yuan (-23.43%), with a non-recurring net profit of 439 million yuan (-25.84%) [2] - In Q1 2025, the company reported revenue of 482 million yuan (-1.92%) and a net profit attributable to shareholders of 143 million yuan (+2.74%), with a non-recurring net profit of 141 million yuan (-9.19%) [2] - The EPS forecasts for 2025-2026 have been adjusted to 4.07 and 5.02 yuan, respectively, with a new forecast for 2027 set at 6.22 yuan, maintaining a target price of 143.10 yuan, corresponding to a PE of 35X for 2025 [2] Market Position - The company's market share in the detector segment continues to rise, with sales revenue from detectors projected at 1.49 billion yuan in 2024 (-11.99%), actively increasing market share despite weak demand [2] - The sales volume of digital X-ray detectors is expected to grow from 91,300 units in 2022 to 119,200 units in 2024, with a global market share reaching 20.09% in 2023, positioning the company as a leader in the global digital X-ray detector industry [2] Business Growth - The new core components and comprehensive solutions business is experiencing rapid growth, with revenue from new core components reaching 126 million yuan (+45.49%) and comprehensive solutions and technical services generating 86.8 million yuan (+226.25%) in 2024 [3] - The company has completed its business layout in high-voltage generators, radiation sources, and tubes, with the economic and mid-to-high-end CT high-voltage generators starting mass production in 2024 [3] Market Expansion - The company is actively expanding both domestic and international markets, enhancing its global service platform with sales or customer service centers established in various countries including the USA, Germany, South Korea, India, Japan, Mexico, Pakistan, Brazil, and South Africa [4] - In 2024, several major clients continued to show healthy growth, with dental products achieving small batch sales overseas and industrial new core components and solutions generating nearly 100 million yuan in revenue [4]

Core Insights - The company Yirui Technology closed at 122.58 yuan, with a 1.30% increase, resulting in a rolling PE ratio of 37.39 times and a total market capitalization of 17.537 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 48.90 times and a median of 36.41 times, Yirui Technology ranks 76th [1] - As of the first quarter of 2025, 47 institutions hold shares in Yirui Technology, with a total of 82.5452 million shares valued at 9.443 billion yuan [1] Company Overview - Yirui Technology specializes in the research, production, sales, and service of digital X-ray detectors, high-voltage generators, combination ray sources, and tube components [1] - The company has successfully mass-produced flat panel detectors and linear array detectors, mastering four sensor technologies: amorphous silicon, IGZO, CMOS, and flexible substrates [1] - These advancements are expected to enhance the company's product line, service diverse customers, and improve market competitiveness and brand influence [1] Financial Performance - In the first quarter of 2025, Yirui Technology reported revenue of 482 million yuan, a year-on-year decrease of 1.92%, while net profit was 143 million yuan, reflecting a year-on-year increase of 2.74% [1] - The sales gross margin stood at 48.92% [1]

股票代码：688301 股票简称：奕瑞科技 债券代码：118025 债券简称：奕瑞转债 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为中金公司所作的承诺 或声明。在任何情况下，投资者依据本报告所进行的任何作为或不作为，中金公 司不承担任何责任。 1 中国国际金融股份有限公司作为奕瑞电子科技集团股份有限公司（以下简称 "奕瑞科技"、"发行人"、或"公司"）向不特定对象发行可转换公司债券（债券 简称："奕瑞转债"，债券代码：118025，以下简称"本次债券"）的保荐机构、 主承销商和受托管理人，持续密切关注对债券持有人权益有重大影响的事项。根 据《公司债券发行与交易管理办法》《公司债券受托管理人执业行为准则》《可转 换公司债券管理办法》等相关规定、本次债券《受托管理协议》的约定以及发行 人于 2025 年 4 月 26 日披露的《奕瑞电子科技集团股份有限公司关于变更注册地 资本、经营范围并修订公司章程的公告》及《奕瑞电子科技集团股份有限公司 2024 年年度报告》，现就本次债券重大事项报告如下： 奕瑞电子科技集团股份有限公司 向不特定对象发 ...

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1][6][7]. Core Insights - The company's main business is stabilizing, with new technologies flourishing, as evidenced by the launch of various innovative products in the medical and industrial sectors [3][4]. - The company reported a revenue of 1.831 billion yuan in 2024, a slight decrease of 1.74% year-on-year, with a net profit of 465 million yuan, down 23.43% year-on-year [3]. - The company is actively expanding its product matrix and has made significant advancements in the development of new core components and X-ray comprehensive solutions [4][6]. Financial Performance Summary - In 2024, the company achieved a revenue of 1.831 billion yuan, with a gross margin of 50.11% and a net margin of 24.59% [3]. - For Q1 2025, the company reported a revenue of 482 million yuan, a year-on-year decrease of 1.92%, but a net profit increase of 2.74% to 143 million yuan [3]. - The company forecasts revenues of 2.162 billion yuan in 2025, with a projected net profit of 574 million yuan, reflecting a growth rate of 18% and 23% respectively [5][6]. Product Development and Market Position - The company has successfully launched several new products, including high-resolution detectors and various X-ray sources, enhancing its competitive edge in the market [3][4]. - The company is focusing on R&D investments in CMOS detectors, CT detectors, and photon counting detectors, which are expected to drive future growth [3][4]. - The company aims to strengthen its position as a core supplier of digital X-ray components and comprehensive solutions through continuous innovation and global business expansion [6].

Core Viewpoint - The financial performance of Yirui Technology in 2024 shows a decline in revenue and net profit, indicating potential challenges in the market despite growth in cash flow from operating activities and increased investment in R&D [1][2][3]. Financial Performance - The company reported a revenue of 1.83 billion, a decrease of 1.74% compared to 2023 [2]. - The net profit attributable to shareholders was 465 million, down 23.43% year-on-year [1][2]. - The gross profit margin was 50.15%, reflecting a decline of 6.83 percentage points from the previous year [2]. Expense Changes - Sales expenses decreased by 13.10% to 69.68 million [3]. - Management expenses increased by 36.02% to 138 million [3]. - R&D expenses reached 310 million, an increase of 18.08%, representing 16.94% of total revenue [3][6]. Cash Flow - The net cash flow from operating activities was 360 million, up 5.91% year-on-year [3]. - The net cash flow from investing activities was -1.13 billion, primarily for ongoing construction projects [3]. - The net cash flow from financing activities increased by 219.67% to 1.15 billion, mainly for project loan financing [3]. Company Overview - Yirui Technology, established on March 7, 2011, specializes in the R&D, production, sales, and service of digital X-ray detectors and related core components [5]. - The company is headquartered in Shanghai, with production bases in Jiangsu, Zhejiang, Anhui, South Korea, and the United States [5]. R&D Investment - R&D investment in 2024 reached 310 million, marking an 18.08% increase [6]. - The company completed 78 IP applications in new core components and scientific instruments, with 37 granted [6]. Sales and Market Position - In 2024, the sales volume of digital X-ray detectors reached 119,200 units, showing a steady growth trend [7]. - Revenue from solutions and technical services amounted to 96.46 million, a significant increase of 262.56% [7].